Background
Molla Donaldson was born on July 15, 1944, in Lancaster, Lancaster Country, Pennsylvania, United States. She is the daughter of Milton B. Sloane, a physician, and Leonore (Chertcoff) Sloane.
Wellesley, Massachusetts, United States
In 1966 Molla Donaldson graduated from the Wellesley College with a Bachelor of Arts degree.
Charlottesville, Virginia, United States
In 1970 Molla Donaldson received a Master of Science degree from the University of Virginia.
Ann Arbor, Michigan, United States
Molla Donaldson had a doctoral study at the University of Michigan.
(The new Agency for Health Care Policy and Research in the...)
The new Agency for Health Care Policy and Research in the U.S. Public Health Service is funding a set of multidisciplinary groups called Patient Outcomes Research Teams (PORTs). Their purpose is to assess alternative treatments for medical conditions using a variety of outcome measures. In guiding insurance coverage, these PORTs are expected to wield considerable influence on medical practice and health policy. This book addresses possible threats to their credibility that might be based on real or apparent conflicts of interest, including both financial and other conflicts. It raises points to consider for the new agency, for PORTs and their institutions, for industry, for the health services research community, and for the U.S. Congress in avoiding and managing conflicts of interest.
http://www.amazon.com/gp/product/0309044820/?tag=2022091-20
1991
(This book contains chapters and commentaries by members o...)
This book contains chapters and commentaries by members of the Institute of Medicine (IOM) committee and by outstanding practitioners, researchers, legislators, and policymakers about the IOM's proposals for new directions in quality assurance as specified in Medicare: A Strategy for Quality Assurance, Volumes 1 and 2. Sections of this new book address ideas about how to move toward increasing professionalism, implementing orgranization and system-focused quality improvement, better decision making by patients and clinicians, patient outcomes orientation, and public accountability and program evaluation. Other sections explore research questions and capacity building in the field of quality assessment and improvement, the epidemiology and quality problems, and legal issues in quality assessment.
http://www.amazon.com/gp/product/0309044294/?tag=2022091-20
1991
(The problem of deciding which health care technologies to...)
The problem of deciding which health care technologies to evaluate is urgent. With new technologies proliferating alongside steadily increasing health care costs, it is critical to discriminate among technologies to direct tests and treatments at those who can benefit the most. Given the vast number of clinical problems and technologies to be evaluated, the many months of work required to study just one problem, and the relatively few clinicians with highly developed analytic skills, institutions must set priorities for assessment. This book sets forth criteria and a method that can be used by public agencies such as the Office of Health Technology Assessment (in the U.S. Public Health Service) and by any private organization conducting such work to decide which technologies to assess or reassess.
http://www.amazon.com/gp/product/0309046963/?tag=2022091-20
1992
(Mifepristone (RU486), the first clinically available anti...)
Mifepristone (RU486), the first clinically available antiprogestin, has generated great interest since its discovery in the early 1980s. Today, it is recognized that mifepristone, along with other antiprogestins, has a potentially significant therapeutic role in human health and disease, with likely applicability to a variety of pregnancy-related conditions (e.g., management of labor) and to contraception, endometriosis, and cancer, among others. But because mifepristone has been studied and used most widely as a means of nonsurgical abortion, political issues have thus far limited research on the drug and prevented its introduction into the U.S. market. This book provides an unbiased evaluation of current knowledge about both the fundamental nature of antiprogestins as well as their possible use in treating numerous diseases and conditions, and it contains recommendations for future research.
http://www.amazon.com/gp/product/0309049490/?tag=2022091-20
1993
(Based on experience with databases now in operation and i...)
Based on experience with databases now in operation and in development, this book provides a clear set of guidelines and principles for exploiting the potential benefits of aggregated health data, without jeopardizing confidentiality. A panel of experts identifies characteristics of emerging health database organizations (HDOs). The committee explores how HDOs can maintain the quality of their data, what policies and practices they should adopt, how they can prepare for linkages with computer-based patient records, and how diverse groups from researchers to health care administrators might use aggregated data. Health Data in the Information Age offers frank analysis and guidelines that will be invaluable to anyone interested in the operation of health care databases.
http://www.amazon.com/gp/product/0309076676/?tag=2022091-20
1994
(This volume makes recommendations for improving primary c...)
This volume makes recommendations for improving primary care, building its organization, financing, infrastructure, and knowledge base, as well as developing a way of thinking and acting for primary care clinicians.
http://www.amazon.com/gp/product/0309053994/?tag=2022091-20
1996
(This book breaks the silence that has surrounded medical ...)
This book breaks the silence that has surrounded medical errors and their consequence, but not by pointing fingers at caring health care professionals who make honest mistakes. After all, to err is human. Instead, this book sets forth a national agenda, with state and local implications, for reducing medical errors and improving patient safety through the design of a safer health system.
http://www.amazon.com/gp/product/0309261740/?tag=2022091-20
2000
Molla Donaldson was born on July 15, 1944, in Lancaster, Lancaster Country, Pennsylvania, United States. She is the daughter of Milton B. Sloane, a physician, and Leonore (Chertcoff) Sloane.
In 1966 Molla Donaldson graduated from the Wellesley College with a Bachelor of Arts degree. In 1970 she received a Master of Science degree from the University of Virginia. Donaldson had a doctoral study at the University of Michigan.
Molla Donaldson served as a research assistant at the George Washington University from 1972 to 1976. She was promoted to a research instructor and worked from 1976 to 1978, then was an assistant research professor of health care sciences from 1978 to 1983. From 1983 to 1988 Donaldson was a director of Research and Quality Assurance Program at the George Washington University Health Plan. From 1984 to 1986 Donaldson was a risk control consultant at the Chartered Institute of Management Accountants (CIMA) at Risk Control Services in Washington, D.C.
In 1985 she was appointed a senior health services researcher at Medical Decision Center of the George Washington University and worked for three years. In 1988 Donaldson became an associate professor and served until 1990. In the same year, Molla Donaldson served as a senior staff officer at the National Academy of Sciences in the Institute of Medicine in Washington, D.C. In 1990 she was a member of advisory council at the Health Care Quality Education Foundation. In 1994 she was appointed an adjunct professor at the George Washington University.
In 1996 Molla Sloane Donaldson was a member of task force on Conduct of Studies at the National Research Council. In 1997 she became a member of steering committee of National Primary Care Consortium at the Primary Care Fellowship Society. In 1998 Donaldson was a speaker at the Virginia Commonwealth University and Medical College of Virginia (VCU Medical Center).
(This book contains chapters and commentaries by members o...)
1991(Based on experience with databases now in operation and i...)
1994(This volume makes recommendations for improving primary c...)
1996(This book breaks the silence that has surrounded medical ...)
2000(Mifepristone (RU486), the first clinically available anti...)
1993(The problem of deciding which health care technologies to...)
1992(The new Agency for Health Care Policy and Research in the...)
1991Molla Donaldson is a member of the Association for Health Services Research, of the American Public Health Association, and of the Sigma Xi.
In 1969 Molla Sloane married Gerald A. Donaldson.